Applied Biosystems and Qiagen, Lehman Brothers and Applied Biosystems, Agilent and NCI, Waters, NSF and USDA, PerkinElmer, and 454 Life Sciences and Washington University | GenomeWeb

Applied Biosystems, Qiagen Ink PCR Licensing Deal

Applied Biosystems has granted a license to Qiagen under an expanded PCR license program that Applied Biosystems launched in June, the companies announced this week.

ABI's expanded program includes patents for real-time PCR and other PCR-related technologies not licensed under its previous PCR licensing program. Specifically, the program includes a license to foundational patents, the TaqMan assay, and the Dye-Intercalation assay method.

Financial terms of the arrangement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."